Improve Compliance in Automated Peritoneal Dialysis Machine With SHARESOURCE

Sponsor
E-DA Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT04157764
Collaborator
(none)
50
1
24

Study Details

Study Description

Brief Summary

This study is to investigate the non-compliance rate of patients undergoing automated peritoneal dialysis by using automated peritoneal dialysis with SHARESOURCE software, and to evaluate if telemonitoring can improve peritoneal dialysis compliance and outcomes in the observation period.

Condition or Disease Intervention/Treatment Phase
  • Device: HomeChoice Claria APD machine with SHARESOURCE
N/A

Detailed Description

The non-compliance of patients receiving automated peritoneal dialysis (APD) is around 10-20%, and was believed to be under-estimated. Recently, a two-way telehealth system, SHARESOURCE software, provide practitioners real-time monitoring and recording of the therapy of APD.

By using this APD with SHARESOURCE software, we want to investigate the non-compliance rate of patients undergoing automated peritoneal dialysis, want to see if it can improve peritoneal dialysis compliance and outcomes in the observation period.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
use automated peritoneal dialysis machine without SHARESOURCE for 12 weeks, then use automated peritoneal dialysis machine with SHARESOURCE for 12 weeksuse automated peritoneal dialysis machine without SHARESOURCE for 12 weeks, then use automated peritoneal dialysis machine with SHARESOURCE for 12 weeks
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Impact of Telemonitoring on Compliance and Outcomes of Patients Undergoing Automated Peritoneal Dialysis With SHARESOURCE
Anticipated Study Start Date :
Feb 1, 2020
Anticipated Primary Completion Date :
Jan 31, 2021
Anticipated Study Completion Date :
Jan 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: APD

Device: HomeChoice Claria APD machine with SHARESOURCE
HomeChoice Claria APD machine with SHARESOURCE software. SHARESOURCE is a software can telemonitor patients' compliance

Outcome Measures

Primary Outcome Measures

  1. Change of baseline patients' non-compliance rate at 3 months [baseline(between week 0 and 12) and 3 months(week 12 and week 24)]

    Non compliance rate was calculated by the days of non-compliance divided by days of APD therapy

Secondary Outcome Measures

  1. Change of baseline peritoneal dialysis adequacy at 3 and 6 months [baseline, week 12 and week 24]

    Dialysis adequacy is to see if dialysis is enough

  2. Change of baseline uremic toxin level at 3 and 6 months [baseline, week 12 and week 24]

    concentration of uremic toxins(ex: indoxyl sulfate, and p-cresyl sulfate)

  3. change of body composition analysis [baseline, week 12 and week 24]

    body composition exam (Body Composition Monitor, Fresenius Medical Care, Bad Homburg, Germany) will be done

  4. peritonitis rate (patient-month) [follow up to week 60]

    calculate the number of peritonitis rate

  5. Hospitalization rate [follow up to week 60]

    calculate the number of hospitalization rate

  6. Change of telephone contact frequency [baseline(between week 0 and 12) and 3 months(week 12 and week 24)]

    the telephone contact frequency (from patient to nurse) for peritoneal dialysis-related problems will be collected

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • stable received peritoneal dialysis for over 1 year. Use automated peritoneal dialysis machine regularly by him/herself.
Exclusion Criteria:
  • Acute hospitalization events due to acute coronary syndrome, stroke, heart failure, liver cirrhosis, systemic infection in 1 month.

  • Life expectancy <1 year

  • Peritoneal dialysis prescriptions will be scheduled or expected to change in 3 months

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • E-DA Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
E-DA Hospital
ClinicalTrials.gov Identifier:
NCT04157764
Other Study ID Numbers:
  • EMRP108057
First Posted:
Nov 8, 2019
Last Update Posted:
Nov 19, 2019
Last Verified:
Nov 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by E-DA Hospital

Study Results

No Results Posted as of Nov 19, 2019